# Dorna Therapeutics, Inc. — Form D

Dorna Therapeutics, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-31. The offering totals $300K, of which $300K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-07-31
- Form: D
- Accession: 0001748360-18-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $300K
- Amount sold: $300K
- Investors: 5
- Date of first sale: 2018-07-18
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-318201

## Issuer

- Name: Dorna Therapeutics, Inc.
- CIK: 0001748360
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 294 FOREST STREET, WALTHAM, MA, 02452
- Phone: 617-906-2696

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Mousa Jafari | Director | Waltham, MA |
| John J Quinn | Director | Indianapolis, IN |
| John Alfons Tabaczynski | Director | Groton, MA |
| Mousa Jafari | Executive Officer | Waltham, MA |
| Mousa Jafari | Promoter | Waltham, MA |
| John Alfons Tabaczynski | Promoter | Groton, MA |

## More

- [CIK 1748360 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1748360&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001748360-18-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.